6-chloro-2,3,4,9-tetrahydro-1H-beta-carbolin-1-one, 100mg

n-(2-Methoxyethyl)-4-nitrobenzenesulfonamide, 95%, 1g

Xanthosine Dihydrate>98.0%(HPLC)(T)100mg

4-Aminobutan-2-ol, 97%, 1g

3-Fluoro-4-(4-methylpiperazin-1-yl)aniline, 95.0%, 25g

6-Piperidin-1-ylnicotinic acid, 97.0%, 1g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide, 97%, 10g

2,2'-(Ethane-1,2-diylbis(oxy))diethanamine, 95.0%, 25g

tert-butanol, min. 99%, for synthesis, 25 l, tinplate

Ethyl 5-benzyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine-7-carboxylate, 97%, 500mg

3-Phenoxy-1-propanol>98.0%(GC)5g

1,1,4,4,7,7,10,10-Octamethyl-2,3,4,7,8,9,10,12-octahydro-1H-dibenzo[b,h]fluorene, 95.0%, 5g

2-CHLORO-3-N-METHYLPYRIDINE-3,4-DIAMINE, 98%, 5g